The Gavi Board approved funding in December 2021 for the roll-out of the world’s first malaria vaccine in sub-Saharan Africa. The vaccine, developed over nearly 35 years, will be deployed from 2022 to 2025.
Malaria Vaccine type
Nearly 35 Years Development period
December 2021 Funding approved
Sub-Saharan Africa Roll-out region
35 Years development time
2022–2025 vaccine rollout duration